| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | - | 1.13e-04 | 6 | 52 | 2 | 3.90.1290.10 | |
| Domain | Plectin_repeat | 1.58e-04 | 7 | 52 | 2 | IPR001101 | |
| Domain | Plectin | 1.58e-04 | 7 | 52 | 2 | PF00681 | |
| Domain | PLEC | 1.58e-04 | 7 | 52 | 2 | SM00250 | |
| Domain | P-loop_NTPase | 4.99e-04 | 848 | 52 | 9 | IPR027417 | |
| Domain | Myosin_N | 7.80e-04 | 15 | 52 | 2 | PF02736 | |
| Domain | Myosin_N | 7.80e-04 | 15 | 52 | 2 | IPR004009 | |
| Domain | Myosin_tail_1 | 1.13e-03 | 18 | 52 | 2 | PF01576 | |
| Domain | Myosin_tail | 1.13e-03 | 18 | 52 | 2 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 1.26e-03 | 19 | 52 | 2 | IPR027401 | |
| Domain | - | 1.26e-03 | 19 | 52 | 2 | 4.10.270.10 | |
| Domain | Actinin_actin-bd_CS | 1.85e-03 | 23 | 52 | 2 | IPR001589 | |
| Domain | ACTININ_2 | 1.85e-03 | 23 | 52 | 2 | PS00020 | |
| Domain | ACTININ_1 | 1.85e-03 | 23 | 52 | 2 | PS00019 | |
| Domain | Cys-rich_flank_reg_C | 2.02e-03 | 90 | 52 | 3 | IPR000483 | |
| Domain | LRRCT | 2.02e-03 | 90 | 52 | 3 | SM00082 | |
| Domain | Spectrin_repeat | 2.94e-03 | 29 | 52 | 2 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 3.57e-03 | 32 | 52 | 2 | IPR018159 | |
| Domain | SPEC | 3.57e-03 | 32 | 52 | 2 | SM00150 | |
| Domain | - | 4.41e-03 | 746 | 52 | 7 | 3.40.50.300 | |
| Domain | Myosin_head_motor_dom | 5.01e-03 | 38 | 52 | 2 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 5.01e-03 | 38 | 52 | 2 | PS51456 | |
| Domain | Myosin_head | 5.01e-03 | 38 | 52 | 2 | PF00063 | |
| Domain | MYSc | 5.01e-03 | 38 | 52 | 2 | SM00242 | |
| Domain | LRRNT | 9.57e-03 | 53 | 52 | 2 | PF01462 | |
| Pubmed | 4.79e-08 | 653 | 53 | 10 | 22586326 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | 5.39e-07 | 647 | 53 | 9 | 26618866 | |
| Pubmed | 7.03e-07 | 331 | 53 | 7 | 29199018 | ||
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | 3.65e-06 | 607 | 53 | 8 | 39147351 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | WHRN SLIT2 NUP107 SRP68 UGGT2 PLEC CFAP418 MORC3 ZW10 DYNC1H1 ARHGAP19 | 4.00e-06 | 1321 | 53 | 11 | 27173435 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | S100A8 DST NUP107 PMPCB ATAD3A SRP68 DLST CHD8 PLEC ARMCX1 DYNC1H1 | 5.03e-06 | 1353 | 53 | 11 | 29467282 |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 19932097 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 22555971 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 7.81e-06 | 477 | 53 | 7 | 31300519 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.14e-05 | 332 | 53 | 6 | 32786267 | |
| Pubmed | 1.30e-05 | 340 | 53 | 6 | 29478914 | ||
| Pubmed | Role of binding of plectin to the integrin beta4 subunit in the assembly of hemidesmosomes. | 1.36e-05 | 4 | 53 | 2 | 14668477 | |
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 19948655 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 22840395 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 4.23e-05 | 853 | 53 | 8 | 28718761 | |
| Pubmed | 4.76e-05 | 7 | 53 | 2 | 10637308 | ||
| Pubmed | SEPTIN8 DST ATAD3A PRMT5 SRP68 DLST PLEC NT5DC3 ELFN2 DYNC1H1 | 5.22e-05 | 1431 | 53 | 10 | 37142655 | |
| Pubmed | 6.34e-05 | 8 | 53 | 2 | 20301543 | ||
| Pubmed | 8.15e-05 | 9 | 53 | 2 | 12482924 | ||
| Pubmed | Retrolinkin, a membrane protein, plays an important role in retrograde axonal transport. | 8.15e-05 | 9 | 53 | 2 | 17287360 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 1.22e-04 | 736 | 53 | 7 | 29676528 | |
| Pubmed | 1.24e-04 | 11 | 53 | 2 | 12802069 | ||
| Pubmed | 1.24e-04 | 11 | 53 | 2 | 10811835 | ||
| Pubmed | Current insights into the formation and breakdown of hemidesmosomes. | 1.24e-04 | 11 | 53 | 2 | 16757171 | |
| Pubmed | 1.37e-04 | 65 | 53 | 3 | 34645483 | ||
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 1.74e-04 | 182 | 53 | 4 | 31067453 | |
| Pubmed | Histone deacetylase 3 modulates Tbx5 activity to regulate early cardiogenesis. | 1.76e-04 | 13 | 53 | 2 | 24565863 | |
| Pubmed | 1.76e-04 | 13 | 53 | 2 | 22962592 | ||
| Pubmed | 1.76e-04 | 13 | 53 | 2 | 9670011 | ||
| Pubmed | 1.76e-04 | 13 | 53 | 2 | 11950896 | ||
| Pubmed | 1.83e-04 | 786 | 53 | 7 | 29128334 | ||
| Pubmed | 1.93e-04 | 187 | 53 | 4 | 26460568 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 2.12e-04 | 357 | 53 | 5 | 37059091 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 2.35e-04 | 197 | 53 | 4 | 20811636 | |
| Pubmed | A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. | 2.70e-04 | 16 | 53 | 2 | 19922871 | |
| Pubmed | RGS4 and RGS5 are in vivo substrates of the N-end rule pathway. | 2.70e-04 | 16 | 53 | 2 | 16217033 | |
| Pubmed | 2.82e-04 | 844 | 53 | 7 | 25963833 | ||
| Pubmed | 3.05e-04 | 17 | 53 | 2 | 22577142 | ||
| Pubmed | FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. | 3.11e-04 | 212 | 53 | 4 | 33462405 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 3.18e-04 | 861 | 53 | 7 | 36931259 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 3.28e-04 | 1149 | 53 | 8 | 35446349 | |
| Pubmed | 3.58e-04 | 878 | 53 | 7 | 37223481 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 4.01e-04 | 410 | 53 | 5 | 26949251 | |
| Pubmed | 4.11e-04 | 638 | 53 | 6 | 33239621 | ||
| Pubmed | 4.25e-04 | 20 | 53 | 2 | 33397958 | ||
| Pubmed | 4.25e-04 | 20 | 53 | 2 | 26876178 | ||
| Pubmed | 4.52e-04 | 234 | 53 | 4 | 36243803 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 5.45e-04 | 942 | 53 | 7 | 31073040 | |
| Pubmed | KLF13 is a genetic modifier of the Holt-Oram syndrome gene TBX5. | 5.65e-04 | 23 | 53 | 2 | 28164238 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 5.69e-04 | 949 | 53 | 7 | 36574265 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 5.95e-04 | 1257 | 53 | 8 | 36526897 | |
| Pubmed | Transcriptomic analysis of the upper lip and primary palate development in mice. | 6.16e-04 | 24 | 53 | 2 | 36685938 | |
| Pubmed | 6.61e-04 | 259 | 53 | 4 | 31162944 | ||
| Pubmed | Patterns of gene expression associated with Pten deficiency in the developing inner ear. | 6.68e-04 | 25 | 53 | 2 | 24893171 | |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | 6.89e-04 | 704 | 53 | 6 | 32994395 | |
| Pubmed | 7.23e-04 | 26 | 53 | 2 | 26857994 | ||
| Pubmed | CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. | 7.28e-04 | 468 | 53 | 5 | 36042349 | |
| Pubmed | 7.35e-04 | 469 | 53 | 5 | 27634302 | ||
| Pubmed | 7.80e-04 | 27 | 53 | 2 | 21983003 | ||
| Pubmed | 7.93e-04 | 272 | 53 | 4 | 31010829 | ||
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | 7.93e-04 | 272 | 53 | 4 | 25315684 | |
| Pubmed | 8.39e-04 | 483 | 53 | 5 | 36912080 | ||
| Pubmed | ISL1 is necessary for auditory neuron development and contributes toward tonotopic organization. | 8.40e-04 | 28 | 53 | 2 | 36074819 | |
| Pubmed | 8.62e-04 | 486 | 53 | 5 | 20936779 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 8.90e-04 | 1024 | 53 | 7 | 24711643 | |
| Pubmed | 9.31e-04 | 284 | 53 | 4 | 29459677 | ||
| Pubmed | 9.53e-04 | 497 | 53 | 5 | 23414517 | ||
| Pubmed | 9.64e-04 | 30 | 53 | 2 | 39366945 | ||
| Pubmed | 9.64e-04 | 30 | 53 | 2 | 37158107 | ||
| Pubmed | 9.83e-04 | 754 | 53 | 6 | 35906200 | ||
| Pubmed | 1.03e-03 | 31 | 53 | 2 | 21985497 | ||
| Pubmed | 1.10e-03 | 32 | 53 | 2 | 21951318 | ||
| Pubmed | 1.15e-03 | 777 | 53 | 6 | 35844135 | ||
| Pubmed | Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development. | 1.17e-03 | 33 | 53 | 2 | 32094117 | |
| Pubmed | 1.17e-03 | 33 | 53 | 2 | 30917309 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 1.22e-03 | 1082 | 53 | 7 | 38697112 | |
| Pubmed | Nuclear pore composition regulates neural stem/progenitor cell differentiation in the mouse embryo. | 1.24e-03 | 34 | 53 | 2 | 18539113 | |
| Pubmed | A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. | 1.24e-03 | 34 | 53 | 2 | 12577067 | |
| Pubmed | 1.31e-03 | 35 | 53 | 2 | 38025786 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 1.34e-03 | 1425 | 53 | 8 | 30948266 | |
| Pubmed | 1.34e-03 | 142 | 53 | 3 | 30809309 | ||
| Pubmed | 1.36e-03 | 1429 | 53 | 8 | 35140242 | ||
| Pubmed | 1.40e-03 | 317 | 53 | 4 | 11042152 | ||
| Pubmed | 1.41e-03 | 809 | 53 | 6 | 32129710 | ||
| Pubmed | 1.43e-03 | 145 | 53 | 3 | 23349634 | ||
| Pubmed | 1.44e-03 | 1442 | 53 | 8 | 35575683 | ||
| Pubmed | 1.48e-03 | 147 | 53 | 3 | 16959763 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | 1.50e-03 | 1451 | 53 | 8 | 30550785 | |
| Pubmed | 1.51e-03 | 148 | 53 | 3 | 35676246 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 1.52e-03 | 552 | 53 | 5 | 10737800 | |
| Cytoband | 4q31.3 | 5.95e-04 | 31 | 53 | 2 | 4q31.3 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.07e-04 | 8 | 36 | 2 | 939 | |
| GeneFamily | Myosin heavy chains | 3.98e-04 | 15 | 36 | 2 | 1098 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 4.45e-03 | 50 | 36 | 2 | 721 | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 3.02e-06 | 189 | 53 | 5 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | RA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 3.02e-06 | 189 | 53 | 5 | b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 3.43e-06 | 194 | 53 | 5 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.59e-05 | 127 | 53 | 4 | 353484362448f27e8377447d0c26391b1da7acc5 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.23e-05 | 163 | 53 | 4 | 431221a41d396b09170476179590eaf8a55266d8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.23e-05 | 163 | 53 | 4 | 1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-non-classical_monocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.22e-05 | 172 | 53 | 4 | 968d18ab8c3cdeb7936a2aa721a7f41525763863 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-Tuft-related-Microfold_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.58e-05 | 175 | 53 | 4 | 8a37b2811f39bb9baa537e8755a29d559eb8185a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_RORB_CARTPT|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.23e-05 | 180 | 53 | 4 | 5e78b29fa1cbdcf502fee3577e5b45766b90d1dc | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 6.36e-05 | 181 | 53 | 4 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 6.64e-05 | 183 | 53 | 4 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.78e-05 | 184 | 53 | 4 | d48807f9da48bdd015a54c606d2e2a311f181396 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.92e-05 | 185 | 53 | 4 | 7925519b855f76444a0b57382ce35d89457b0b14 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|normal_Lymph_Node / Location, Cell class and cell subclass | 7.37e-05 | 188 | 53 | 4 | e83de94a9b47a6a90e98face887eae031a322af6 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 7.68e-05 | 190 | 53 | 4 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | CTRL-Myeloid-Alveolar_Macrophage|Myeloid / Disease state, Lineage and Cell class | 8.15e-05 | 193 | 53 | 4 | 80871d963c23a6befe58e5e60b7f7d1a1b227ce2 | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 8.65e-05 | 196 | 53 | 4 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.83e-05 | 197 | 53 | 4 | d968d7d5608b175bb567ea3a315bf473ec3be459 | |
| ToppCell | 15-Distal-Mesenchymal-Mesenchyme_RSPO2+|Distal / Age, Tissue, Lineage and Cell class | 9.00e-05 | 198 | 53 | 4 | e87d1fe2befbd32b0c723ab43b9de95495ea3ee3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.18e-05 | 199 | 53 | 4 | 85bb28369e0568b7b3bda095722102fc793f60ef | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.18e-05 | 199 | 53 | 4 | 4e518651ff219e163cfd9deb58566df6308aa3f7 | |
| ToppCell | mLN-(4)_Monocyte|mLN / shred on region, Cell_type, and subtype | 9.18e-05 | 199 | 53 | 4 | 6795ff31f92580195c9db776951f99d647484d24 | |
| ToppCell | Mild-Myeloid-Macrophages-FCN1+SPP1+|Mild / Condition, Lineage, Cell class and cell subclass | 9.18e-05 | 199 | 53 | 4 | 2cbaef86af870a228cb46895dd765ea8894c83c5 | |
| ToppCell | Mild_COVID-19-Myeloid-TRAM3|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 9.18e-05 | 199 | 53 | 4 | 4ab5da8ab757e8294c743949a5374b6e6a388913 | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM3-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.18e-05 | 199 | 53 | 4 | af167e7a16c3537ce0aa821f608cdcb0c3abc07f | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM3-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.18e-05 | 199 | 53 | 4 | 4b88ce864dc75ed8596a076ce4498f73639bbac8 | |
| ToppCell | BAL-Mild-Myeloid-TRAM|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.18e-05 | 199 | 53 | 4 | 8a31a459491aa8625802c5211d38d57c1e8be76b | |
| ToppCell | mLN-Monocyte|mLN / Region, Cell class and subclass | 9.18e-05 | 199 | 53 | 4 | 241f790cd5d8a9b2451333deecc826a673bae70a | |
| ToppCell | mLN-(4)_Monocyte-(40)_Monocyte|mLN / shred on region, Cell_type, and subtype | 9.18e-05 | 199 | 53 | 4 | bcbb1eee8d79bf670dbe113094c3a292b135ce2f | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM3|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.18e-05 | 199 | 53 | 4 | bae7aa25f9e23fea19371390b8306e9dc3e4d549 | |
| ToppCell | Mild-Myeloid-Macrophages-FABP4+|Mild / Condition, Lineage, Cell class and cell subclass | 9.18e-05 | 199 | 53 | 4 | 7bfd6ca4b0f2683715c24dfd7cf40418b5b8ddf2 | |
| ToppCell | mLN-Monocyte-Monocyte|mLN / Region, Cell class and subclass | 9.18e-05 | 199 | 53 | 4 | dcee372774c169a3048bdaed3734b3215bf8ffad | |
| ToppCell | BAL-Mild-Myeloid-TRAM|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.18e-05 | 199 | 53 | 4 | 27c63da6b29a1fc57ed2568443ba5029f3cdb186 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Glia_progenitor_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 9.36e-05 | 200 | 53 | 4 | 4b937b1d0179d1d0e51931f35720e205d460a07e | |
| ToppCell | COVID|World / Condition, Cell_class and T cell subcluster | 9.36e-05 | 200 | 53 | 4 | 04a932fe2431e7886120c219ce666f90d3030a1c | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.51e-04 | 103 | 53 | 3 | 3baaf23a9756be41af3a9b4f720e3ab00f1b674d | |
| ToppCell | LPS-IL1RA-Myeloid-Myeloid_granulocytic-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.74e-04 | 118 | 53 | 3 | 6053e19d040fb394f9c270361af07b0c5a4d47db | |
| ToppCell | LPS-IL1RA-Myeloid-Myeloid_granulocytic|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.74e-04 | 118 | 53 | 3 | 811e8521129914eef46785a4227c1860e77d9096 | |
| ToppCell | severe-unassigned|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.75e-04 | 128 | 53 | 3 | bef9cf0078fa8498d63f0723f1fa4a3c92405e10 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.97e-04 | 130 | 53 | 3 | 793c42602dde22da0715a5304ea70d791fdd5354 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-naive_thymus-derived_CD8-positive,_alpha-beta_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.67e-04 | 136 | 53 | 3 | 9d7080f695de4ef183e3dbdc18ba464a3b8e3469 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-IRC-IFNG_responsive_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.67e-04 | 136 | 53 | 3 | 7f1ca43e0d164b511120316d4218d80ba21a9b5c | |
| ToppCell | primary_visual_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.29e-04 | 141 | 53 | 3 | 605d7b28e99c943f64b4095855a6f9f70e92cb09 | |
| ToppCell | Mild/Remission-B_naive-1|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.56e-04 | 143 | 53 | 3 | bd3f5fbd4e9e4dc414682db5607494f3ce988deb | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.69e-04 | 144 | 53 | 3 | c0c5f254a960ba5e5f1354599d54e77360e6c2ac | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Neutrophil|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.69e-04 | 144 | 53 | 3 | 1efa434e577d1f87e02df01667782f414d63bd60 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Monocytic-Cycling_mono|bone_marrow / Manually curated celltypes from each tissue | 7.24e-04 | 148 | 53 | 3 | de35eeefad0e27a0d127e2e4bedead2bddb75152 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D175|Adult / Lineage, Cell type, age group and donor | 7.24e-04 | 148 | 53 | 3 | 012845b10850bbc67814da247ee5a69f6d631eaa | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.97e-04 | 153 | 53 | 3 | e0fbbfd4d13031412e0b985322c8b99c56eb7af5 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.13e-04 | 154 | 53 | 3 | c6ecc46b99a783373729f7fae0b23216148ffb78 | |
| ToppCell | PBMC-Control-cDC_1|Control / Compartment, Disease Groups and Clusters | 8.43e-04 | 156 | 53 | 3 | 9b6c5bcac516a62bcc1f5be32ffa8c92735ef0bc | |
| ToppCell | facs-Brain_Myeloid-Cerebellum|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-04 | 156 | 53 | 3 | 28c4fb4d2c6c47696c3a6722998f9da5a8923323 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.91e-04 | 159 | 53 | 3 | 6c0ef40f64d2e35eaae3d0002e3c1f22d1239736 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.91e-04 | 159 | 53 | 3 | 745a59c33b04620c5329bdd50e74a8e611f2dc55 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 9.24e-04 | 161 | 53 | 3 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | Severe-Lymphoid-NK-CCR7+_T|Severe / Condition, Lineage, Cell class and cell subclass | 9.57e-04 | 163 | 53 | 3 | 8f0d8c124f1569a5a6bc1db7581989f24d63cca3 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-03 | 166 | 53 | 3 | 7c2eee0a4f45795a956acf936b85bdb35f1b1624 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-03 | 166 | 53 | 3 | 7286a37b2827f3747469ffd0d76cbe81116db7ee | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-03 | 166 | 53 | 3 | 9d4b44eb56ad38c26aed73444edf389abca6bdf6 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-03 | 167 | 53 | 3 | a82e85caf79395baa48380786d9df32a86dfd1ce | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-03 | 167 | 53 | 3 | 528493896aebe7d03d4b6ad2341b12927859e2e4 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-8|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.04e-03 | 168 | 53 | 3 | 00646601548b0fee42ae16bfa5e93603bc7c5129 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-03 | 168 | 53 | 3 | 435ef2e4d702e978d54f9d1f5a047f39c691cc63 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.04e-03 | 168 | 53 | 3 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-03 | 169 | 53 | 3 | 0332f539a2f7d6dcd081a5d2f567290721f5a329 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-03 | 169 | 53 | 3 | c3d410a5e98000ba872141b62e17ef4ed3d1a8eb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-03 | 169 | 53 | 3 | 2e15a9317da4017757d184f7cc91bd66b072ac51 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-03 | 170 | 53 | 3 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-03 | 170 | 53 | 3 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.08e-03 | 170 | 53 | 3 | 07b561cd9c528bc8444c9385e1de621eee7b697e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-03 | 170 | 53 | 3 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-03 | 171 | 53 | 3 | 3d26ef58fe5231373d7df9ac79d225546918cf82 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-mature_enterocytic-Colonocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-03 | 171 | 53 | 3 | 0597339618fb4d416d55c538eceb353218a55002 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-03 | 171 | 53 | 3 | effcc4b6d26eafc2ca6fa08b6fee2689eff48f0f | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-03 | 171 | 53 | 3 | 0de81d12a8000f2c59cdb214e67dc526d18098fe | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-03 | 172 | 53 | 3 | a9e13aa36087170dadca421ba9de588e5a1cf715 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|ILC / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-03 | 172 | 53 | 3 | 4977e1f4deae781750e27a8054deccd336cfb74a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic-Neutrophil|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-03 | 172 | 53 | 3 | c32e6af9e2d29da47b5d870207b598cff11aef6c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-03 | 172 | 53 | 3 | 0b247fe57163af08132db8df42e6757699885295 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-03 | 172 | 53 | 3 | 1a0556c97fcba126126c22adea5235d977d41ebe | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 1.14e-03 | 173 | 53 | 3 | 42c911ed16fabdabef063830e8407192d8bde950 | |
| ToppCell | ILEUM-non-inflamed-(3)_Inf._Macrophages|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.14e-03 | 173 | 53 | 3 | a8db746992a915a8431ac5c155612e89c4af3cad | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|lymph-node_spleen / Manually curated celltypes from each tissue | 1.14e-03 | 173 | 53 | 3 | 783b8fa08b9d8f597f251793eae164151662f1f9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-03 | 173 | 53 | 3 | 0a0127bcb1d7b2b6125faef576dd843055095528 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.6.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-03 | 175 | 53 | 3 | baaffc9af61f12168d6f7b96eb0b6e98a44a3909 | |
| ToppCell | droplet-Tongue-nan-24m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-03 | 176 | 53 | 3 | 9739b0653c511ab017507a0c7ee4f6d7082e87db | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 1.21e-03 | 177 | 53 | 3 | 52c2ba74a8605260a2623e7d151286e504ac4d19 | |
| ToppCell | metastatic_Brain-Fibroblasts-Undetermined|metastatic_Brain / Location, Cell class and cell subclass | 1.21e-03 | 177 | 53 | 3 | 54f39be5d90363cfd44dea1a96ae06d3143aa795 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.21e-03 | 177 | 53 | 3 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.23e-03 | 178 | 53 | 3 | 8f31b3fac51591f7f2bcb898c07708b3e9f93a16 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-03 | 178 | 53 | 3 | a95bb77a2c2ce7c38989e6f971812f7ee9f5bd4b | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 1.25e-03 | 179 | 53 | 3 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | RSV-Healthy-0|RSV / Virus stimulation, Condition and Cluster | 1.27e-03 | 180 | 53 | 3 | 974044056e2f7e909cb11c6f6ca89e58bf95f7e5 | |
| ToppCell | VE-mono2-|VE / Condition, Cell_class and T cell subcluster | 1.27e-03 | 180 | 53 | 3 | 188e7c65e9a86771f89029b18dfb3216b2c9d7d7 | |
| ToppCell | RSV-Healthy-0|Healthy / Virus stimulation, Condition and Cluster | 1.27e-03 | 180 | 53 | 3 | 703a1d0f9536af94d56757eb01221878d7b7fe61 | |
| ToppCell | 5'-Adult-LymphNode-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-03 | 180 | 53 | 3 | cc974ac352ef2adc953fb5f325880e5857595889 | |
| ToppCell | VE-mono2|VE / Condition, Cell_class and T cell subcluster | 1.27e-03 | 180 | 53 | 3 | 494d00672f20ceffa7054a31e617fb7ec72e56e9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-03 | 181 | 53 | 3 | 04c278ad22e32a4f75af92fc9bfe439363c04f90 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.29e-03 | 181 | 53 | 3 | 7225361d8854de6be34d40845e50978d93a88a5d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-03 | 181 | 53 | 3 | 6d80795f96aac11fec1c946d1f2d16cfe6e38d9a | |
| Computational | Neighborhood of CSNK1D | 1.09e-04 | 71 | 38 | 4 | MORF_CSNK1D | |
| Drug | 2,2'-dipyridylamine | 2.58e-06 | 12 | 53 | 3 | CID000014547 | |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 6.12e-05 | 7 | 51 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.31e-04 | 10 | 51 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.31e-04 | 10 | 51 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.31e-04 | 10 | 51 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.31e-04 | 10 | 51 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.31e-04 | 10 | 51 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.31e-04 | 10 | 51 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.31e-04 | 10 | 51 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.31e-04 | 10 | 51 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 1.91e-04 | 12 | 51 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.91e-04 | 12 | 51 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 2.26e-04 | 13 | 51 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | Left ventricular noncompaction | 2.63e-04 | 14 | 51 | 2 | C1960469 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 3.03e-04 | 15 | 51 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | hypertrophic cardiomyopathy (is_implicated_in) | 6.62e-04 | 22 | 51 | 2 | DOID:11984 (is_implicated_in) | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 7.78e-04 | 239 | 51 | 4 | EFO_0010934 | |
| Disease | Limb-girdle muscular dystrophy | 9.27e-04 | 26 | 51 | 2 | cv:C0686353 | |
| Disease | Alcoholic Intoxication, Chronic | 1.19e-03 | 268 | 51 | 4 | C0001973 | |
| Disease | solar lentigines measurement | 1.41e-03 | 32 | 51 | 2 | EFO_0007850 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KILFPGKTNNHMLKL | 886 | Q13523 | |
| LKLTFQKHKLMANGV | 2261 | Q9HCK8 | |
| KRLGMFNIQHCKKLS | 246 | P01009 | |
| KTLFAKKLALHSGMD | 406 | Q9NVI7 | |
| FRNNMPEFHKLKAKL | 156 | Q96NL8 | |
| KSHMKSRGDTLAFFK | 176 | Q8N4G2 | |
| KFLRGLGNKMKFLHK | 1121 | P78524 | |
| QGNAIMRKFLASKKH | 691 | P57740 | |
| SKKSSKGVHFMFLAK | 576 | Q7Z3E1 | |
| KLTGAIMHFGNMKFK | 351 | P12883 | |
| MTFKAKLFDNHLGKS | 546 | P12883 | |
| KLKKHSMDFLLFQFG | 56 | O95453 | |
| HFLEHMAFKGTKKRS | 101 | O75439 | |
| FLKNVLKDLGHTKMQ | 3556 | Q03001 | |
| KFFHSLLGTNAKMLI | 156 | P50135 | |
| KIVGALLHFGNMKFK | 396 | A7E2Y1 | |
| KLHKMLSFGFSDKVT | 76 | Q14149 | |
| GHTKKMNFFKVGKHF | 146 | Q8N3Z3 | |
| HLAKFLRNKMDVPSK | 176 | P35227 | |
| LKKHNLKLGFMSAFV | 271 | P36957 | |
| NPGHLKKAKLMFFFT | 441 | Q3B8N5 | |
| FLAMSKKGKLHASAK | 141 | P12034 | |
| HIQEMKKNALLLFKG | 616 | Q05DH4 | |
| KSNKKLFELFTIHLM | 611 | Q96M89 | |
| LHFMASVKKKAIGSQ | 2541 | Q9H799 | |
| SLFAFLEHRKMKKSL | 61 | Q92819 | |
| FLTNKKGFPVLSKMH | 236 | O14744 | |
| NVAKLQKHFKKMFAG | 1646 | Q14204 | |
| QKHFKKMFAGVSSII | 1651 | Q14204 | |
| GANLRHLQAMKKFVK | 236 | P21452 | |
| FTSFGKKLTKNKMLH | 401 | Q9UKG9 | |
| KMKGFTVSLKSLKHF | 451 | Q2TAK8 | |
| FLILVIKMGVAAHKK | 71 | P05109 | |
| FLSKETKHMLKILNF | 426 | A2VDJ0 | |
| AKDMKHRLGFLLQKS | 16 | P49798 | |
| NELSKKHMVQFLSGK | 1221 | Q8IVG5 | |
| AKLADHGKKMFLITN | 286 | Q86UY8 | |
| SLRNKHIKGAMKTFF | 291 | O76100 | |
| MKVLFGHLTKIVAKA | 406 | Q53QZ3 | |
| MALFKLLNTHAKFSL | 461 | Q9P202 | |
| MNLGQFLEFLKKHKS | 261 | Q9UIY3 | |
| KTLNFKMGNRHKFTG | 96 | Q9UHB9 | |
| LFLGNHFTKIQIMKL | 336 | Q9P291 | |
| LFLLKLARHSKFGMK | 451 | Q16620 | |
| KAFIFQSSLKKHMRS | 291 | Q13360 | |
| LHKFKIKIMGELVSN | 196 | Q92599 | |
| NVQHKMFKGLESLKT | 596 | O94813 | |
| GMAFMIKHSQKLFKA | 296 | Q14CB8 | |
| SLFQAMKKGLILKDH | 4161 | Q15149 | |
| KGFVMFSILAKHKVI | 1176 | O43345 | |
| CGKAFMFKSKLVRHQ | 471 | Q9BWM5 | |
| TAAALGMHQKKHLFK | 1136 | Q8NAP3 | |
| KPSGRKLLFNALKHM | 751 | Q9NYU1 | |
| LTLKFTMHLFKLKDS | 126 | Q0VDI3 | |
| ELHSKLKSFGQMLLK | 236 | O43264 | |
| MAAGHALRKKVQFAK | 786 | Q5R3F8 |